PH30494A - A process for preparing antitumor and anti-bacterial substituted disulfide derivatives from compounds possessing a methyltrithio group - Google Patents

A process for preparing antitumor and anti-bacterial substituted disulfide derivatives from compounds possessing a methyltrithio group

Info

Publication number
PH30494A
PH30494A PH44225A PH44225A PH30494A PH 30494 A PH30494 A PH 30494A PH 44225 A PH44225 A PH 44225A PH 44225 A PH44225 A PH 44225A PH 30494 A PH30494 A PH 30494A
Authority
PH
Philippines
Prior art keywords
methyltrithio
bacterial
group
compounds possessing
preparing antitumor
Prior art date
Application number
PH44225A
Inventor
Mcgahren William James
Sassiver Martin Leon
George A Ellestad
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of PH30494A publication Critical patent/PH30494A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • A61K47/6809Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH44225A 1989-04-14 1992-04-20 A process for preparing antitumor and anti-bacterial substituted disulfide derivatives from compounds possessing a methyltrithio group PH30494A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33932389A 1989-04-14 1989-04-14
PH4036890 1990-04-11

Publications (1)

Publication Number Publication Date
PH30494A true PH30494A (en) 1997-05-28

Family

ID=23328476

Family Applications (1)

Application Number Title Priority Date Filing Date
PH44225A PH30494A (en) 1989-04-14 1992-04-20 A process for preparing antitumor and anti-bacterial substituted disulfide derivatives from compounds possessing a methyltrithio group

Country Status (5)

Country Link
KR (1) KR0159767B1 (en)
CA (1) CA2014486C (en)
PH (1) PH30494A (en)
SG (1) SG47848A1 (en)
ZA (1) ZA902840B (en)

Also Published As

Publication number Publication date
ZA902840B (en) 1991-12-24
KR0159767B1 (en) 1998-11-16
CA2014486C (en) 2002-10-29
CA2014486A1 (en) 1990-10-14
SG47848A1 (en) 1998-04-17
KR900016243A (en) 1990-11-13

Similar Documents

Publication Publication Date Title
HU910400D0 (en) Process for producing 3-aryl-carbonyl-1h-indole derivatives
HU911492D0 (en) Process for producing bis-aryl-amide and -urea derivatives
HUT57790A (en) Process for producing deoxyfluoronucleoside derivatives
HUT53588A (en) Process for producing naphtalene derivatives
HU903908D0 (en) Process for producing new r(-)-3-quinuclidinole derivatives
GR910100427A (en) Process for preparing 8-chloroquinolone derivatives
HUT67129A (en) A process for preparing dinitrotolvene
HU912693D0 (en) Process for producing indolo-naphtyridine derivatives
HU912732D0 (en) Process for producing 1-alkyl-isoquinoline derivatives
HU906520D0 (en) Process for producing diaza-bicycloamine derivatives
HU907221D0 (en) Process for producing cepheme derivatives
HU910326D0 (en) Process for producing 2-chloro-5-methyl-pyridine derivatives
CS649989A3 (en) Process for preparing cyclosporin a derivatives
EP0503603A3 (en) Process for preparing 2-exo-methylene-penam derivatives
PH30494A (en) A process for preparing antitumor and anti-bacterial substituted disulfide derivatives from compounds possessing a methyltrithio group
AU616337B2 (en) A process for preparing naphthalene derivatives
HUT67269A (en) Process for preparing benzofuranyl-imidazole derivatives
EP0463470A3 (en) Process for the preparation of a fluorotetrahydrofuranone derivative
GB9123241D0 (en) A process for preparing a pharmaceutical composition
HUT58284A (en) Process for producing alkyl-sulfonanilide derivatives
HU912413D0 (en) Process for producing n-alkyl-sulfonyl-amino-sulfonyl-urea derivatives
HUT56067A (en) Solvent-free process for producing pyridinyl-oxy-phenoxy-propionate derivatives
YU81090A (en) Process for preparing polycyclical compounds
HUT54164A (en) Process for producing acylrifamycin derivatives
HUT53884A (en) Process for producing 1-aryl-sulfonyl-pirrolidine-2-thion- and 1-arylsulfonyl-piperidine-2-thion derivatives